chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Dizziness, Myalgia, Sensation of throat selling and itching Narrative:  Employee self-treated at home with OTC Benadryl.
Explosive diaper/Had diarrhea; Upset stomach; Hard time sleeping; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (Hard time sleeping), DIARRHOEA (Explosive diaper/Had diarrhea) and ABDOMINAL DISCOMFORT (Upset stomach) in a 10-month-old male infant exposed to mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023C21A) , while the mother received the product for COVID-19 vaccination.     No Medical History information was reported.    On 06-May-2021, the mother received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 06-May-2021, the infant was diagnosed with INSOMNIA (Hard time sleeping) and ABDOMINAL DISCOMFORT (Upset stomach). On 07-May-2021, the infant was diagnosed with DIARRHOEA (Explosive diaper/Had diarrhea). The Infant was exposed to mRNA-1273 (Moderna COVID-19 Vaccine) during pregnancy.  At the time of the report, INSOMNIA (Hard time sleeping), DIARRHOEA (Explosive diaper/Had diarrhea) and ABDOMINAL DISCOMFORT (Upset stomach) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Upon in internal review on 17 May 2021, the age was corrected to 10 months.   This case was linked to US-MODERNATX, INC.-MOD-2021-114699, US-MODERNATX, INC.-MOD-2021-114699 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-114699:Mother's case US-MODERNATX, INC.-MOD-2021-114699:Mother's case
Vaccinee rec'd a first Engerix-B vax on 13SEP90; Onset of events occurred the same day; Currently, vaccinee is "better".
I woke up with a massive headache and a sore throat on day one. For the first 5 days I woke up to a splitting headache. Tuesday May 03,  I took a 2nd COVID-19 test which was positive. At that point the sore throat was moderate. No congestion, My cough peaked around May 4 and 5th. The nasal and chest congestion started then as well. I am still testing positive. I went to the doctor on Wednesday May 04. They confirmed I was positive and recommended OTC medication. I have taken Excedrin just to tackle the headache. I still have mild chest congestion and a faint sore throat.
No additional AEs; inadvertently administering VARlVAX on 03AUG2021 after the product expired on 25JUN2021; This spontaneous report as received from a medical assistant and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.     On 03-AUG-2021, the patient was inadvertently vaccinated with an expired dose of varicella virus vaccine live (oka/merck)(VARIVAX) lot # S019584 was confirmed to be valid, expiration date 25-JUN-2021, 1 dosage form (route of administration, anatomical location were not reported) for prophylaxis. No additional adverse effect was reported. The reporter confirmed that this product did not have any known temperature excursions.
tingling in neck and arm that received injection. Palpitations, blurry vision.  Patient had taken zyzal and benadryl (both antihistamines) which probably caused the blurred vision.  Heart rate was checked and was normal.  She has a history of anaphylaxis.
Expired vials were used (1st dose); This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vials were used (1st dose)) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vials were used (1st dose)). On 27-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Expired vials were used (1st dose)) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medication was provided.  No vial had undergone any temperature excursions. There were no adverse reactions to the vaccine as reported.    Most recent FOLLOW-UP information incorporated above includes: On 18-Nov-2021: Follow up received : Product Administration dates were updated. On 19-Nov-2021: Follow up received : Patient's first name and last name updated On 19-Nov-2021: Follow up received : reporter Information updated.
Patient was given .5 of TD right deltoid localized reaction about 30 X 30 mm warm to the touch.  Imm. given at local TDHP
Pt developed paresthesia in lower extremities and was admitted inpatient at local hospital and diagnosed with Transverse Myelitis bilateral Lower Extremities; April 15, 2022.
I had a severe case of the flu, terrible body aches, could not get out of bed for two days, nausea, etc.  The same thing happened when I received the first dose.
Extreme, unusual  alopecia areata, way more than age related.  Noticed by patient @ 3 months post second shot.  Has rapidly increased over past 6 months.  Hair does not seem to be growing back.  Patient trying Hair Solution over past 8 weeks -no noticeable results.  Patient has found increasing number of reports of similar unusual amounts of hair loss.
The symptoms started 3 hours after the 2nd dose of COVID. I felt pain in my left arm ( the same arm where I was injected ), chills and fever across my body, sweating, numbness and electric tingling in head, dizziness and vertigo with sensation of wanting to vomit, a lot of pain in my joints, watery eyes and pain in my eyeballs, lack of equilibrium and orientation, and other symptoms.
Patient came in for her second Covid vaccine approximately at 4:15 pm today.  She was told to stay in the store for 15 minutes.  After her and her finance left the store, her throat started to close up and she could not breathe.  She told him to take her back to our store ASAP.  When she got into the building she was struggling to breathe.  I gave her a dose of epinephrine in her left thigh and had my tech call 911.  EMTs arrived, gave her oxygen, got to to sit up, put her on a gurney to take her to the ambulance for observation.  They let her go home.  Her finance is watching her.
customer fainted after vaccine, he says he is scare of blood. there is few  blood underneath the bandage. customer did not had breakfast before IMZ,  and customer  is fear of blood , confirmed with  his mother.
Information has been received from a physician concerning his daughter a 25 year old female who in April 2007, was vaccinated with a first dose of GARDASIL (route and administrating site not reported). In June 2007, the patient was vaccinated with a second dose of GARDASIL (route and administrating site not reported). In October 2007, the patient was vaccinated with a third dose of GARDASIL (route and administrating site not reported). In approximately November 2007, the patient experienced symptoms indicative of autoimmune disorder. Specialists were looking at her having either scleroderma or dermatomycosis. The patient's autoimmune disorder persisted and was considered to be disabling. Additional information has been requested.
I had a presyncope 5-10 mins after COVID vacc #1 on 12/26/20. Required oral fluids and food. Then, was sick for the following 3 days with COVID symptoms, with another presyncopal episode on 12/27 and multiple COVID symptoms.
Erythematous welt on (L) upper arm measurement 20cm long x 11cm wide, redness and warm to touch. Pruritus present.
Had Dose 1 ca 10:00 AM (late for 8:20 AM appt - wrong onsite location); ca 11:15/11:30 AM - sleepy/ drowsy, runny nose; ca 12:00 P - REQ 2 puffs of Xopenex rescue inhaler (breathless feeling;  felt a deep heavy band across diaphragm area/ just below lungs - very diff from the stifled feeling typical to having an asthma attack, mine milder - a weighted heavyness to breathing), brain felt foggy, lightheaded (enough to be fearful of driving main or busier residential roads over the next 15 mins to arrive at apartment); ca 1:00 PM - single puff of Xopenex inhaler; drove home arriving ca 1:25 PM - felt wiped-out, very foggy brained, achy, headache & took Allegra 24 hour #3 dose, exceptionally groggy; napped heavily till ca 4:30/ 4:45 PM - less foggy, less exhausted, not confident in clear-headedness, did not feel sharp in perception enough to make contact tracing phone calls; 5:00 PM - clocked in to work remotely for 3 hours of professional reading, catch up with some regional, state pandemic happenings.
This spontaneous report as received from a medical assistant refers to an unspecified number of patients of unknown age and gender. No information regarding pertinent medical history, drug reactions/allergies and concomitant medications were reported. On 18-JUN-2015, the patients were vaccinated with a dose of improperly stored PROQUAD (Merck) (lot number: K020747, expiration date: 30-APR-2016) (dose and route were not reported). No adverse effects were reported. There was no product quality issue reported. Follow-up information was received on 03-AUG-2015 and 05-AUG-2015. The reporting certified medical assistant would have to search the request made for patients' identifiers, lot numbers and expiration dates and dates of vaccination. Follow-up information has been received from the medical assistant's clinic on 22-OCT-2015, regarding a 4-year-old patient of unknown gender. On 22-JUN-2015, the patient was vaccinated with a dose of improperly stored PROQUAD (Merck), lot # confirmed as K020747. This is one of several reports received from the same source. Additional information has been requested. Patient's details, product and event information and narrative were updated.
Diagnosed with Myasthenia Gravis (autoimmune disease)  5/13/09 hospital records received DOS 11/25/08 to 11/27/08. FINAL DIAGNOSIS: Myasthenia gravis, viral meningitis Post vaccination droopy left eyelid, difficulty running, weak grip, mouth and jaw fatigue, diplopia, dizziness. Admitted for IVIG treatment. Headache, increased ptosis, upper and lower extremity weakness. Nausea, vomiting  5/14/09 Received Neuro medical records of 11/24/2008. FINAL DX: myasthenia gravis Records reveal patient experienced weakness x 2 mo starting w/left eyelid droop, then mouth weakness, arm heaviness, grip strength decreased, leg stiffness, difficulty arising from sitting position, diplopia, intermittent left lazy eye, mouth/jaw fatigue, tiredness, slurred speech, DOE, heartburn, difficulty chewing & swallowing, loss of balance, loss of memory, urinary frequency esp at night.  Sent to hospital for CT, IVIG x 2 days, steroids.  5/18/09 Received PCP medical records of 10/21/08-2/25/2009. Records reveal patient experienced fatigue, dizziness, blurred vision, gen weakness, difficulty concentrating & memory retention difficulties x approx 1 mo when seen 10/21.  Referred to Rheum.  No further visits until 2/25/09 s/p myasthenia gravis.    5/18/09 Received medical records from Rheum but was only labs of 11/19/2008.
C/O Itching to left arm after receiving injection.  No prior reaction/issue with first dose.  HR 62 SpO2 98.  Medicated with 25mg PO Benadryl
Per PCP clinic note 9/7/22: "Annular skin lesions-patient has a new skin lesion explosions over his shin abdomen for over the past 6 months getting worse.  No pus drainage no fevers.  No pets at home."  He was started on triamcinolone cream.  2/24/23 he followed up in clinic with progressive symptoms and was diagnosed with plaque psoriasis and started on benadryl cream as well.  He was referred to dermatology and saw them in clinic 3/28/23.  He has stopped taking all other prescription medications for several months 2/2 financial limitation, but the rash persisted.  He was diagnosed with psoriasis and given no new medications. 4/2 he was admitted to the hospital migratory pain complaints.  Admitting MD noted "Patient's rash ranges from nonblanching somewhat petechial rash almost resembles small hemangiomas to areas where it is confluent and the skin is actually breaking down. "  He was admitted to treat possible autoimmune vasculitis, with confirmatory labs pending.
The patient called early this morning to inform she felt like she had the flu shortly after the shot.  Said her head hurt and had body aches.  She had a stuffy nose and a scratchy throat.  She slept terrible last night.  No reported fever though.  She strongly felt that it was due to the vaccine.  I recommended Tylenol, rest, and fluids and to call her doctor if worse or felt like she needed to be seen.
On 10-19-12 pt received FLUZONE vaccine to (L) deltoid. 12 hours later began facial itching and swelling radiating to trunk. Treated with BENADRYL every six hours.
Shortness of breath, weakness, and redness and swelling near injection site on left deltoid  Symptoms started approximately 12 hours after vaccination and lasted about 24-48 hours with symptoms dissipating over time. Symptoms had resolved within 72 hours.
Flu-like symptoms, high fever (103) for two days and mild fever (101) for one day, sore throat, muscle ache, headache, cough, sinus and chest congestion, malasia. Symptoms for more than 6 days.
Liver enzymes elevated; This spontaneous case was reported by a patient and describes the occurrence of HEPATIC ENZYME INCREASED (Liver enzymes elevated) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031M20A and 007B21A) for an unknown indication.     The patient's past medical history included No adverse event (Medical history was not provided.). Concomitant products included AMLODIPINE, METFORMIN, GABAPENTIN, HYDROCHLOROTHIAZIDE, VALSARTAN (VALSARTAN & HCTZ), POTASSIUM, LEVOTHYROXINE, ATORVASTATIN CALCIUM (LIPITOR), FUROSEMIDE (LASIX [FUROSEMIDE]), ASPIRIN [ACETYLSALICYLIC ACID] and CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for an unknown indication.   On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to dosage form. On an unknown date, the patient experienced HEPATIC ENZYME INCREASED (Liver enzymes elevated). At the time of the report, HEPATIC ENZYME INCREASED (Liver enzymes elevated) outcome was unknown.
Hard circle near injection site; Redness/2 inches diameter red near injection site; Swollen near injection site; Vaccination site tenderness; Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION (Hard circle near injection site), VACCINATION SITE ERYTHEMA (Redness/2 inches diameter red near injection site), VACCINATION SITE SWELLING (Swollen near injection site), VACCINATION SITE PAIN (Vaccination site tenderness) and FATIGUE (Tiredness) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     Concurrent medical conditions included Exercise induced asthma (mild) since 2010. Concomitant products included THERAGRAN M from 01-Jan-1978 to an unknown date for an unknown indication.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 08-Jan-2021, the patient experienced VACCINATION SITE PAIN (Vaccination site tenderness) and FATIGUE (Tiredness). On 18-Jan-2021, the patient experienced VACCINATION SITE INDURATION (Hard circle near injection site), VACCINATION SITE ERYTHEMA (Redness/2 inches diameter red near injection site) and VACCINATION SITE SWELLING (Swollen near injection site). On 12-Jan-2021, VACCINATION SITE PAIN (Vaccination site tenderness) and FATIGUE (Tiredness) had resolved. On 25-Jan-2021, VACCINATION SITE INDURATION (Hard circle near injection site), VACCINATION SITE ERYTHEMA (Redness/2 inches diameter red near injection site) and VACCINATION SITE SWELLING (Swollen near injection site) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Treatment information was not provided.   This case was linked to MOD-2021-199359 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 01-Jun-2021: No significant information was received.Reporter contact information is updated On 02-Jun-2021: Events and concomitant medication added, action taken, event information, patient information and reporter causality updated.
Significant pain in right lower rib area, imitating symptoms of fractured rib, feels incredibly sore to the touch. Hard to carry or lift anything. Cannot lean on it. Has persisted 5 days after shot.
Patient states that on the 2nd day after receiving the vaccine she developed cellulitis around the injection site (warmth, redness, itching).  She was seen by an MD and prescribed antibiotics.  She states the symptoms are resolving.
I had sore throat, running nose, and cough. It was cold symptoms. These lasted for about 4 days. On Jan 14th, I tested positive for COVID-19.
Right hip and thigh edema,erythema.Decreased range of motion of right hip.Large gluteal abscess requiring incision/drainage and IV antibiotics.Wound culture positive for Strep Pneumoniae.Tx w/ oral antibiotics for 7 days at home after D/C.
COVID-19; Cough; Itching at injection site; Fatigue; Red skin at injection site; This spontaneous case was reported by a nurse and describes the occurrence of COVID-19 (COVID-19), COUGH (Cough), VACCINATION SITE PRURITUS (Itching at injection site), FATIGUE (Fatigue) and VACCINATION SITE ERYTHEMA (Red skin at injection site) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Dec-2020, the patient experienced COUGH (Cough), VACCINATION SITE PRURITUS (Itching at injection site), FATIGUE (Fatigue) and VACCINATION SITE ERYTHEMA (Red skin at injection site). On 03-Jan-2021, the patient experienced COVID-19 (COVID-19). At the time of the report, COVID-19 (COVID-19), COUGH (Cough), VACCINATION SITE PRURITUS (Itching at injection site), FATIGUE (Fatigue) and VACCINATION SITE ERYTHEMA (Red skin at injection site) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Jan-2021, SARS-CoV-2 test: positive (Positive) POSITIVE.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 11-Jan-2021: Follow-up information received  and does not contain any new information.; Sender's Comments: Based on the current available information and  temporal association between the use of the product and start date of the events, a causal relationship cannot be excluded. However, the event of COVID -19 POSITIVE  is Unlikely related to mRNA-1273. Further information has been requested
Administered with expired COVID vaccine; Error resulting in administration of expired COVID vaccine; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered with expired COVID vaccine) and PRODUCT ADMINISTRATION ERROR (Error resulting in administration of expired COVID vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered with expired COVID vaccine) and PRODUCT ADMINISTRATION ERROR (Error resulting in administration of expired COVID vaccine). On 08-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Administered with expired COVID vaccine) and PRODUCT ADMINISTRATION ERROR (Error resulting in administration of expired COVID vaccine) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported.  No treatment information was provided by the reporter.  As per the reporter, there were no symptoms or quality issue to report.
Burning on administration of Engerix-B 20/20 employees vaxed; some employees who had recvd prior doses of Hep B vax w/Recomb were to complete schedules w/Engerix B; other recvd Engerix-B 1st time;
Patient present to urgent care (and subsequently) pharmacy with redness. Severe swelling, and pain of his left arm two days after pneumonia vaccine. His wife, who had the same vaccine, was experiencing the same symptoms. Doctor diagnosed as cellulitis and prescribed KEFLEX 500MG TID for 7 days.
This case was reported by a consumer via call center representative and described the occurrence of injection site reaction in a adult female patient who received SHINGRIX. On 15th May 2018, the patient received SHINGRIX. In May 2018, less than a week after receiving SHINGRIX, the patient experienced injection site reaction. On an unknown date, the outcome of the injection site reaction was not recovered/not resolved. It was unknown if the reporter considered the injection site reaction to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient experienced local injection site reactions. The patient received an inbound cell phone call and hung up abruptly to answer that call. No additional details were gathered.
Tingling in arms and legs; Can't stand up; Dizziness; GI blowup; GERD; Burping; Confusion; Brain fog; No energy; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling in arms and legs), ASTHENIA (Can't stand up), DIZZINESS (Dizziness), GASTROINTESTINAL INFECTION (GI blowup) and GASTROOESOPHAGEAL REFLUX DISEASE (GERD) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Acid reflux (esophageal). Concomitant products included LOSARTAN and OMEPRAZOLE MAGNESIUM (PRILOSEC [OMEPRAZOLE MAGNESIUM]) for an unknown indication.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, the patient experienced PARAESTHESIA (Tingling in arms and legs), ASTHENIA (Can't stand up), DIZZINESS (Dizziness), GASTROINTESTINAL INFECTION (GI blowup), GASTROOESOPHAGEAL REFLUX DISEASE (GERD), ERUCTATION (Burping), CONFUSIONAL STATE (Confusion), FEELING ABNORMAL (Brain fog) and FATIGUE (No energy). At the time of the report, PARAESTHESIA (Tingling in arms and legs), ASTHENIA (Can't stand up), DIZZINESS (Dizziness), GASTROINTESTINAL INFECTION (GI blowup), GASTROOESOPHAGEAL REFLUX DISEASE (GERD), ERUCTATION (Burping), CONFUSIONAL STATE (Confusion), FEELING ABNORMAL (Brain fog) and FATIGUE (No energy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       07 Dec 2020 Patient thinks he had COVID-19 but could not get tested. Patient lost sense of taste and smell and other neurological symptoms such as muscle cramping. Symptoms lingered through January. Treatment for the events included rest.